Since we have previously demonstrated the effect of XIAP inhibition on BC cells [21] and the fact that our clinical samples showed that XIAP overexpression does significantly worsen the overall survival of patients who are overexpressing PARP protein, we sought to examine the effect of combining olaparib and embelin on BC cell viability and apoptosis. This evidence concerns the gene PARP1 and breast cancer.